Neuravive, the MR-guided focused ultrasound treatment for medication-refractory essential tremor, will soon become a Medicare covered benefit in 38 states. The Future Effective Local Coverage Determinations for Noridian (Jurisdictions E and F) have posted positive coverage for an additional 13 States as of April 1, 2019. INSIGHTEC is continuing efforts to increase Medicare coverage so that more patients have access to this procedure.
It is our understanding that per Medicare Rules and Regulations, Medicare beneficiaries traveling outside of their home state for treatment at a facility providing MRgFUS would be subject to the Medicare contractor coverage decision based on where the treatment is performed. We recommend confirming with your local Medicare contractor prior to treatment.